Incyte

63 email addresses found for incyte.com
{first}.{l}@incyte.com
63 email addresses
http://adammatira.tk/news/u.s.-fda-extends-review-period-for-baricitinib,-an-investigational-rheumatoid-arthritis-treatment January 1, 2017
http://asiafreshnews.wordpress.com June 6, 2016
http://asiafreshnews.wordpress.com/2016/06/10 June 6, 2016
http://asiafreshnews.wordpress.com/category/uncategorized June 6, 2016
http://asianetpakistan.com/general/263584/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://bioflorida.com/news/news.asp November 11, 2016
http://boersen.manager-magazin.de/spon/news_news.htn May 5, 2016
http://businessinsights.pk/2017/02/14/151160/european-commission-approves-once-daily-olumiant-tablets-for-treatment-of-adults-with-moderate-to-severe-active-rheumatoid-arthritis March 3, 2017
http://curetoday.com/events/mpn September 9, 2015
http://fiercebiotech.com/biotech/lilly-and-incyte-announce-submission-of-new-drug-application-to-fda-for-oral-once-daily November 11, 2016
http://health-fitness.news-articles.net/content/baricitinib-demonstrates-early-response-compared-placebo-significant-improvement-adalimumab-patient-reported-outcomes.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/baricitinib-significantly-reduces-joint-damage-progression-rheumatoid-arthritis-patients-who-respond-conventional-dmards.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/new-analyses-phase-trials-show-improvements-rheumatoid-arthritis-symptoms-following-treatment-baricitinib-across-diverse-population-patients.xhtml November 11, 2016
http://investor.agenusbio.com/2017-02-14-incyte-and-agenus-amend-collaboration-agreement February 2, 2017
http://medialinepakistan.com/category/medical-health-care June 6, 2016
http://m.firstwordpharma.com/european-commission-approves-once-daily-olumiant-tablets-treatment-adults-moderate-severe-active February 2, 2017
http://netherlandscorporatenews.com/archive/en/2016/05/09/y020.htm May 5, 2016
http://newsmakers.pk/story/74654.html/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewsindex.com/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards September 9, 2016
http://pakistannewsreleases.com/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-2 June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-3 June 6, 2016
http://pakistannewswire.net/european-commission-approves-once-daily-olumiant-tablets-for-treatment-of-adults-with-moderate-to-severe-active-rheumatoid-arthritis March 3, 2017
http://prnewswire.com/news-releases/us-fda-extends-review-period-for-baricitinib-an-investigational-rheumatoid-arthritis-treatment-300390987.html March 3, 2017
http://prnewswire.my/news-releases/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-582334851.html October 10, 2016
http://qlifepro.com/press/20160516-19-27093/de-ma-incyte-corporation-2 March 3, 2017
http://research-tree.com/newsfeed/newsrelease/85642 June 6, 2016
http://research-tree.com/newsfeed/newsrelease/85643 June 6, 2016
http://rxtimes.com/incytes-jakafi-ruxolitinib-to-be-featured-in-over-60-abstracts-at-ash-annual-meeting-2 August 8, 2016
http://adammatira.tk/news/u.s.-fda-extends-review-period-for-baricitinib,-an-investigational-rheumatoid-arthritis-treatment January 1, 2017
http://asiafreshnews.wordpress.com June 6, 2016
http://asiafreshnews.wordpress.com/2016/06/10 June 6, 2016
http://asiafreshnews.wordpress.com/category/uncategorized June 6, 2016
http://asianetpakistan.com/general/263584/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://bioflorida.com/news/news.asp November 11, 2016
http://businesswire.com/news/home/20160601005239/en August 8, 2017
http://businesswire.com/news/home/20170221005036/en/incyte-present-upcoming-investor-conferences September 9, 2017
http://businesswire.com/news/home/20170418005028/en/incyte-report-quarter-financial-results August 8, 2017
http://careers.biospace.com/news/eli-lilly-incyte-rheumatoid-arthritis-drug/392923 January 1, 2016
http://fiercebiotech.com/biotech/lilly-and-incyte-announce-submission-of-new-drug-application-to-fda-for-oral-once-daily November 11, 2016
http://health-fitness.news-articles.net/content/baricitinib-demonstrates-early-response-compared-placebo-significant-improvement-adalimumab-patient-reported-outcomes.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/baricitinib-significantly-reduces-joint-damage-progression-rheumatoid-arthritis-patients-who-respond-conventional-dmards.xhtml November 11, 2016
http://health-fitness.news-articles.net/content/new-analyses-phase-trials-show-improvements-rheumatoid-arthritis-symptoms-following-treatment-baricitinib-across-diverse-population-patients.xhtml November 11, 2016
http://investor.agenusbio.com/2017-02-14-incyte-and-agenus-amend-collaboration-agreement February 2, 2017
http://investor.incyte.com/phoenix.zhtml April 4, 2016
http://medialinepakistan.com/category/medical-health-care June 6, 2016
http://m.firstwordpharma.com/european-commission-approves-once-daily-olumiant-tablets-treatment-adults-moderate-severe-active February 2, 2017
http://netherlandscorporatenews.com/archive/en/2016/05/09/y020.htm May 5, 2016
http://newsmakers.pk/story/74654.html/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewsindex.com/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards September 9, 2016
http://pakistannewsreleases.com/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-2 June 6, 2016
http://pakistannewswire.net/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-3 June 6, 2016
http://prnewswire.my/news-releases/baricitinib-significantly-reduces-joint-damage-progression-in-rheumatoid-arthritis-in-patients-who-do-not-respond-to-conventional-dmards-582334851.html October 10, 2016
http://quotes.wsj.com/incy August 8, 2017
http://research-tree.com/newsfeed/newsrelease/85642 June 6, 2016
http://research-tree.com/newsfeed/newsrelease/85643 June 6, 2016
http://rxtimes.com/incytes-jakafi-ruxolitinib-to-be-featured-in-over-60-abstracts-at-ash-annual-meeting-2 August 8, 2016
Show more results
53 more results for incyte.com. Sign up or log in to access the full and uncovered results.

Add the leading solution to find professional email addresses to your toolkit.

Hunter is already trusted by more than 1,000,000 professionals to build more connections and grow their business. Start today and get 100 free searches/month..

Google
IBM
Microsoft
Shopify
Adobe
Oracle

More information about incyte.com

Language of the website: English